Toggle navigation
Home
Search
Services
Blog
Contact
About
Gene Therapy for Squamous Cell Cancer
Ledley, Fred D.
Valentis, Inc., Burlingame, CA, United States
Search 16 grants from Fred Ledley
Search grants from Valentis, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Dynorphin/kappa-opioid receptor regulation of nucleus accumbens synaptic transmission
Central memory CD4 T cell infection: key role in ART response and HIV persistence
Alzhelmer's Disease Drug Development Program
Child/Adolescent Anxiety Multimodal Treatment Study
Macaque studies of correlates of HIV protection
Recently added grants:
Multivalent DNA vaccine-mediated protection against Tuberculosis
Host Genes Critical for Flavivirus Infection
The integrated stress response in stem cells and cancer
ST8Sia6 expression on tumors inhibits the immune response
A-Z Clinical Trials Unit
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44AR042111-02
Application #
2081299
Study Section
Special Emphasis Panel (ZRG7-SSS-2 (22))
Project Start
1993-03-26
Project End
1998-05-31
Budget Start
1996-06-15
Budget End
1997-05-31
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Valentis, Inc.
Department
Type
DUNS #
City
Burlingame
State
CA
Country
United States
Zip Code
94010
Related projects
NIH 1997
R44 AR
Gene Therapy for Squamous Cell Cancer
Ralston, Robert O. / Valentis, Inc.
NIH 1996
R44 AR
Gene Therapy for Squamous Cell Cancer
Ledley, Fred D. / Valentis, Inc.
Comments
Be the first to comment on Fred Ledley's grant